Palivizumab is used in certain infants and young
children to prevent serious lung infections (such as pneumonia) that are
caused by a certain virus (respiratory syncytial virus-RSV). Palivizumab
works by preventing the growth of the virus. This medication is not used to
treat RSV infection, but should be continued even if your child gets the
RSV infection to prevent a more serious infection.
Read the Patient Information Leaflet if available from
your health care professional before your child starts receiving
palivizumab and before each injection. If you have any questions, ask your
doctor or pharmacist.
This medication is given into a muscle (usually the
thigh) by a health care professional as directed by your child's doctor,
usually once a month during RSV season. RSV season in the northern
hemisphere usually starts in October and runs through April. The dosage is
based on your child's weight.
Your child should receive this medication regularly to
get the most benefit from it. To help you remember, mark your calendar with
a reminder.
Fever or pain/redness/swelling at the injection site may
occur. If any of these effects last or get worse, tell your doctor or
pharmacist promptly.
Remember that this medication has been prescribed
because the doctor has judged that the benefit to your child is greater
than the risk of side effects. Many people using this medication do not
have serious side effects.
A very serious allergic reaction to this drug is rare.
However, get medical help right away if you notice any symptoms of a
serious allergic reaction, including:
- rash
- itching/swelling (especially of the face/tongue/throat)
- severe dizziness
- trouble breathing
This is not a complete list of possible side effects. If
you notice other effects not listed above, contact your doctor or
pharmacist.
In the US - Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088 or at
www.fda.gov/medwatch.
In Canada - Call your doctor for medical advice about
side effects. You may report side effects to Health Canada at
1-866-234-2345.
Before using palivizumab, tell the doctor or pharmacist
if your child is allergic to it; or if your child has any other allergies.
This product may contain inactive ingredients, which can cause allergic
reactions or other problems. Talk to your pharmacist for more
details.
Before using this medication, tell the doctor or
pharmacist your child's medical history, especially of:
- bleeding/blood clotting problems (such as low platelets,
coagulation disorder)
Before having surgery (especially certain heart
procedures), tell the doctor or dentist about this medication and all the
products your child uses (including prescription drugs, nonprescription
drugs, and herbal products).
This medication is not usually used by adults. It is
unlikely to be used during pregnancy or breastfeeding. Consult your doctor
if you have any questions about this medication
Drug interactions may change how your medications work
or increase your risk for serious side effects. This document does not
contain all possible drug interactions. Keep a list of all the products you
use (including prescription/nonprescription drugs and herbal products) and
share it with your doctor and pharmacist. Do not start, stop, or change the
dosage of any medicines without your doctor's approval.
This medication may interfere with certain lab tests
(such as RSV diagnostic tests, virus culture tests), possibly causing false
test results. Make sure lab personnel and all your doctors know you use
this drug.
If someone has overdosed and has serious symptoms such
as passing out or trouble breathing, call 911. Otherwise, call a poison
control center right away. US residents can call 1-800-222-1222. Canada
residents can call 1-844-764-7669.
Keep all medical and lab appointments.
It is important to get each dose of this medication as
scheduled. If your child misses a dose, ask the doctor or pharmacist right
away for a new dosing schedule.
Not applicable. This medication is given in a clinic and
will not be stored at home.